DOI: 10.1055/s-00000029

Journal of Reconstructive Microsurgery

Referenz

Joseph RW, Elassaiss-Schaap J, Kefford R. , et al.
Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab.

Clin Cancer Res 2018;
24 (20) 4960-4967

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: